Medial Research Network


news image

How to Successfully Implement Home Healthcare with Direct-to-Patient IMP Delivery Webinar

2 November 3 P.M. London/10 A.M. New York

In this, the 3rd in a series of webinars focussed on the benefits of taking a patient-centric approach to pharmaceutical development, Medical Research Network (MRN) and World Courier discuss the practical aspects of Home Trial Support and Direct to Patient Deliveries. 

Key Learning Objectives

  • Understand the practical implications affecting patient recruitment and retention
  • Hear about the value of a one stop shop and how quality and compliance are improved and competitive advantage can be gained
  • Understand how the practicalities of set up and implementation can make or break a study
  • Uncover the impact a patient-centric approach can have on trials and patients

Recruiting patients and retaining their participation in a clinical trial remain the biggest challenges faced by pharmaceutical companies when developing new medicines. For a patient, participation in a clinical trial can be stressful and burdensome, resulting in one in four patients dropping out of a clinical trial prior to completion. With sponsors facing tight-timelines, increased regulatory scrutiny and spiralling budgets the desire to address these challenges has never been more prominent.

Taking a patient-centric approach and making the individual rather than the site the focal point of the study is now a common theme in addressing the challenge. An increasingly common example of this philosophy in practice is the concept of Home Trial Support and Direct to Patient delivery. By relocating the clinical trial to the patient’s home through trained medical personnel and specialised logistics capabilities it minimizes the inconvenience to patients, increasing the possibility they consent to participate in a clinical trial and reduces the possibility they withdraw from the study prior to its completion. 

Join us for the next World Courier and MRN webinar, where we explore how practical knowledge and experience are the keys to successfully improving patient experience and moving medicine forwards. 

Presented by:


Stuart Redding,

Vice President of Global Business Development

Stuart has over 20 years’ experience in the pharmaceutical industry, successfully delivering clinical trials, with a focus on patient recruitment & retention. Stuart has worked across many disciplines, including data management, clinical operations, project management, feasibility, budget & proposal development, business development & marketing. Stuart worked with both Sponsors (American Cyanamid, Novo Nordisk) & CROs (MDS Harris, Chiltern), before joining MRN in 2006 as one of the founders &Head of Project Management. Stuart currently has responsibility for global business development & marketing, with a focus on educating customers in how to utilise home healthcare for successful clinical trial completion. 


David Spillett,

Key Account Director

David is a pharmaceutical services professional with over 15 years' experience in the provision of GXP compliant services. He is considered a subject matter expert in the context of Clinical Trial Supplies and is one of the few GMP/GDP specialists whose experience includes the administration of investigational products in a clinical setting. David is currently Key Account Director at World Courier where he is often called upon to assist in solving the supply chain challenges associated with novel therapies. He has previously worked as a Clinical Supplies Lead for Penn Pharma where he managed pharmaceutical development and supply chain projects for a variety of small, medium and large pharmaceutical companies. David holds a post graduate diploma in clinical research gained whilst working as a Research Physiologist at Simbec Research Ltd.


Sign up for our Newsletter